Dr. Daniel Gaius Dawson II, MD

Dr. Dawson practices at Florida Eye Clinic P A in Clermont, Florida.

Dr. Dawson's NPI, 1659310779, was assigned on June 5, 2006. Dr. Dawson graduated from Carver College of Medicine in 1997. Dr. Dawson holds Florida license ME94457.

Dr. Dawson's primary practice is Florida Eye Clinic P A, at 2460 E Hwy 50, Clermont, FL 34711 in Lake County. The practice phone is (407) 834-7776.

Dr. Dawson's primary practice is Florida Eye Clinic P A in Clermont, Florida. Dr. Dawson is also affiliated with AdventHealth Orlando. The medical group on file is Florida Eye Clinic. Dmand AI also links Dr. Dawson to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dawson practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Dawson's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Dawson is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Dawson's licenses on file in 4 states: Florida, New Hampshire, North Dakota and Wisconsin.

Dmand AI lists cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Dawson treats.

CMS data shows 1,036 Medicare services from Dr. Dawson across 15 procedure codes in 2024, for 481 Medicare patients. Medicare paid $86,331 for them.

CMS counts 481 Medicare patients who saw Dr. Dawson in 2024. The largest group is 65 to 74, with 194 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dawson's median patient age at 71, with 56% women.

In 2024, Dr. Dawson wrote 6,204 Medicare Part D claims for 1,578 patients. 58% of them were for generic drugs. CMS names the drug for 6,103 of them, across 42 drugs with 11 or more claims each, at $642,712 in total drug cost. In 2023, CMS named 6,020 claims across 40 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Dawson for performance year 2024, reported as part of a group. Dr. Dawson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 55 procedures of cataract surgery by Dr. Dawson, more than 65% of the clinicians it reports for that procedure.

Dmand AI links 39 papers to Dr. Dawson, published from 2008 to 2023. 2013 was the busiest year, with 3. The most frequent topics are Keratomileusis, Laser In Situ, Cornea and Postoperative Complications. Dr. Dawson has published most often in Arch Ophthalmol. Dr. Dawson's most frequent co-authors are Michael W. Belin, MD, Terrence P. O'Brien, MD and Sander R. Dubovy, MD.

CMS Open Payments shows 118 general payments to Dr. Dawson from 21 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $1,254.

Dmand AI lists 1 award for Dr. Dawson, most recently CMS Stage 1 EHR in 2013.

Dr. Dawson graduated from Carver College of Medicine in 1997.

Dr. Dawson is in network with 21 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 14. Check the plan with the practice before a visit.